In vivo editing of lung stem cells for durable gene correction in mice
Science · 14.06.2024 · 384 (6701) · 1196-1202
DOI: 10.1126/science.adk9428 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, erschienen am 14.06.2024. Verfasst von Yehui Sun und 29 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Department of Biochemistry, Simmons Comprehensive Cancer Center, Program in Genetic Drug Engineering, The Unive…. Hauptthemen laut MEDLINE: Cystic Fibrosis, Cystic Fibrosis Transmembrane Conductance Regulator, Gene Editing, Liposomes. Die Arbeit wurde bisher 201-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIBIB NIH HHS.
Abstract (Originalsprache)
In vivo genome correction holds promise for generating durable disease cures; yet, effective stem cell editing remains challenging. In this work, we demonstrate that optimized lung-targeting lipid nanoparticles (LNPs) enable high levels of genome editing in stem cells, yielding durable responses. Intravenously administered gene-editing LNPs in activatable tdTomato mice achieved >70% lung stem cell editing, sustaining tdTomato expression in >80% of lung epithelial cells for 660 days. Addressing cystic fibrosis (CF), NG-ABE8e messenger RNA (mRNA)–sgR553X LNPs mediated >95% cystic fibrosis transmembrane conductance regulator (CFTR) DNA correction, restored CFTR function in primary patient-derived bronchial epithelial cells equivalent to Trikafta for F508del, corrected intestinal organoids and corrected R553X nonsense mutations in 50% of lung stem cells in CF mice. These findings introduce LNP-enabled tissue stem cell editing for disease-modifying genome correction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, Department of Biochemistry, Simmons Comprehensive Cancer Center, Program in Genetic Drug Engineering, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
- Department of Genetics and Genome Sciences, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA.
- ReCode Therapeutics, Menlo Park, CA 94025, USA.
- Department of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
ORCID-Profile: Yehui Sun, Sumanta Chatterjee, Sandhya R Sattiraju, Yufen Xiao, Yun-Chieh Sung, Sang M Lee, Stephen Moore, Di Zhang, Shiying Wu, Pratima Basak, Jialu Wang, Rachel J Mann, David F LePage, Weihong Jiang, Mirko Hennig, Anna Martinez, Mitchell L Drumm, Craig A Hodges, Daniel J Siegwart
Förderung
- NCI NIH HHS
- NIBIB NIH HHS
Zitieren
APA
Sun, Y., Chatterjee, S., Lian, X., Traylor, Z., Sattiraju, S. R., Xiao, Y., Dilliard, S. A., Sung, Y. C., Kim, M., Lee, S. M., Moore, S., Wang, X., Zhang, D., Wu, S., Basak, P., Wang, J., Liu, J., Mann, R. J., LePage, D. F., …, & Siegwart, D. J. (2024). In vivo editing of lung stem cells for durable gene correction in mice. Science, 384(6701), 1196-1202. https://doi.org/10.1126/science.adk9428
Vancouver
Sun Y, Chatterjee S, Lian X, Traylor Z, Sattiraju SR, Xiao Y, et al. In vivo editing of lung stem cells for durable gene correction in mice. Science. 2024;384(6701):1196-1202. doi:10.1126/science.adk9428
BibTeX
@article{Sun2024,
author = {Sun, Yehui and Chatterjee, Sumanta and Lian, Xizhen and Traylor, Zachary and Sattiraju, Sandhya R and Xiao, Yufen and Dilliard, Sean A and Sung, Yun-Chieh and Kim, Minjeong and Lee, Sang M and Moore, Stephen and Wang, Xu and Zhang, Di and Wu, Shiying and Basak, Pratima and Wang, Jialu and Liu, Jing and Mann, Rachel J and LePage, David F and Jiang, Weihong and Abid, Shadaan and Hennig, Mirko and Martinez, Anna and Wustman, Brandon A and Lockhart, David J and Jain, Raksha and Conlon, Ronald A and Drumm, Mitchell L and Hodges, Craig A and Siegwart, Daniel J},
title = {In vivo editing of lung stem cells for durable gene correction in mice},
journal = {Science},
year = {2024},
volume = {384},
number = {6701},
pages = {1196--1202},
doi = {10.1126/science.adk9428}
}
EUVIMED